1. Percent of patients receiving influenza vaccinations figure 5
Percent of patients receiving influenza vaccinations figure 5.1, hemodialysis patients, by HSA, unadjusted
Percent of patients
66.3+ (71.3)
60.2 to <66.3
55.2 to <60.2
47.2 to <55.2
below 47.2 (37.6)

2. Percent of patients hospitalized figure 5
Percent of patients hospitalized figure 5.2, hemodialysis patients, by HSA, Q pts, admitted Q1 2000, unadjusted
Percent of patients
30.2+ (31.5)
29.2 to <30.2
28.2 to <29.2
26.8 to <28.2
below 26.8 (25.4))

3. Percent of patients dying figure 5
Percent of patients dying figure 5.3, hemodialysis patients, by HSA, Q pt cohort, died in Q1 2000, unadjusted
Percent of patients
6.77+ (6.98)
6.60 to <6.77
6.41 to <6.60
6.13 to <6.41
below 6.13 (5.89)

4. Pre- & post-ESRD patients (age 67+) care for influenza vaccinations figure 5.4, by age, & race/ethnicity, fall of pre-ESRD to fall of post-ESRD

5. Pre- & post-ESRD patients (age 67+) care for pneumonia vaccinations figure 5.5, by age, & race/ethnicity

6. Vaccination rates in the two years pre-ESRD & two years post-ESRD figure 5.6, ESRD patients 67+, by HSA, unadjusted
Percent of patients
34.9 (37.7)
31.4 to <34.9
29.0 to <31.4
26.5 to <29.0
below 26.5 (23.5)

7. Pre- & post-ESRD patients diabetic care: receiving diabetic eye exams figure 5.7, patients 67+, by race/ethnicity

8. Pre- & post-ESRD patients diabetic care: receiving lipid testing figure 5.8, patients 67+, by race/ethnicity

9. Pre- & post-ESRD patients diabetic care: receiving glycosylated hemoglobin testing figure 5.9, patients 67+, by race/ethnicity

10. Diabetic eye exams in ESRD & non-ESRD patients: ESRD patients figure 5
Diabetic eye exams in ESRD & non-ESRD patients: ESRD patients figure 5.10, patients age 65–75, by HSA, unadjusted
Percent of patients
60.0+ (62.8)
59.4 to <60.0
59.0 to <59.4
58.5 to <59.0
below 58.5 (57.7)

11. Diabetic eye exams in ESRD & non-ESRD patients: general Medicare patients figure 5.10, patients age 65–75, by HSA, unadjusted
Percent of patients
60.0+ (64.8)
59.4 to <60.0
59.0 to <59.4
58.5 to <59.0
below 58.5 (54.8)

12. Diabetic eye exams in ESRD patients figure 5
Diabetic eye exams in ESRD patients figure 5.11, patients age 18–75, by age, race/ethnicity, & modality

13. Lipid monitoring in diabetic patients: ESRD patients figure 5
Lipid monitoring in diabetic patients: ESRD patients figure 5.12, patients age 65–75, by HSA, unadjusted
Percent of patients
65.1+ (72.0)
60.4 to <65.1
56.4 to <60.4
42.9 to <56.4
below 42.9 (35.9)

14. Lipid monitoring in diabetic patients: general Medicare patients figure 5.12, patients age 65–75, by HSA, unadjusted
Percent of patients
65.1+ (68.9)
60.4 to <65.1
56.4 to <60.4
42.9 to <56.4
below 42.9 (NA)

15. Lipid monitoring in diabetic patients figure 5
Lipid monitoring in diabetic patients figure 5.13, patients age 18–75, by age, race/ethnicity, & modality

16. Glycosylated hemoglobin (HbA1c) testing in diabetic patients: ESRD patients figure 5.14, patients age 65–75, by HSA, unadjusted
Percent of patients
78.4+ (81.1)
75.1 to <78.4
72.2 to <75.1
61.5 to <72.2
below 61.5 (51.5)

17. Glycosylated hemoglobin (HbA1c) testing in diabetic patients: general Medicare patients figure 5.14, patients age 65–75, by HSA, unadjusted
Percent of patients
78.4+ (80.5)
75.1 to <78.4
72.2 to <75.1
61.5 to <72.2
below 61.5 (60.7)

18. Glycosylated hemoglobin (HbA1c) monitoring in diabetic patients figure 5.15, patients age 18–75, by age, race/ethnicity, & modality

19. Frequency of Glycosylated hemoglobin (HbA1c) testing in ESRD & general Medicare patients figure 5.16, patients age 65–75, by the number of tests in pts surviving 1 year

20. Patients receiving breast cancer screening figure 5
Patients receiving breast cancer screening figure 5.17, female ESRD patients age 52–69, by HSA, unadjusted
Percent of patients
42.5+ (43.9)
41.8 to <42.5
41.0 to <41.8
39.9 to <41.0
below 39.9 (38.6)

21. Patients receiving cervical cancer screening figure 5
Patients receiving cervical cancer screening figure 5.18, female ESRD patients age 21–64, by HSA, unadjusted
Percent of patients
41.2+ (43.1)
39.3 to <41.2
37.6 to <39.3
36.7 to <37.6
below 36.7 (35.5)

22. Patients receiving prostate cancer screening figure 5
Patients receiving prostate cancer screening figure 5.19, male ESRD patients age 50+, by HSA, unadjusted
Percent of patients
36.4+ (43.0)
32.7 to <36.4
29.9 to <32.7
26.6 to <29.9
below 26.6 (23.6)

23. Breast cancer screening figure 5
Breast cancer screening figure 5.20, female ESRD patients age 52–69, by age, race/ethnicity, & modality

24. Breast cancer screening in ESRD & general Medicare patients figure 5
Breast cancer screening in ESRD & general Medicare patients figure 5.21, female patients age 52–69, by age, race/ethnicity, & patient pop.

25. Cervical cancer screening figure 5
Cervical cancer screening figure 5.22, female ESRD patients age 21–64, by age, race/ethnicity, & modality

26. Cervical cancer screening in ESRD & general Medicare patients figure 5
Cervical cancer screening in ESRD & general Medicare patients figure 5.23, female patients age 52–69, by age, race/ethnicity, & patient pop.

27. Prostate cancer screening figure 5
Prostate cancer screening figure 5.24, male ESRD patients age 50+, by age, race/ethnicity, & modality

28. Prostate cancer screening in ESRD & general Medicare patients figure 5
Prostate cancer screening in ESRD & general Medicare patients figure 5.25, male patients age 50+, by age, race/ethnicity, & patient pop.